BRKR – Bruker Corporation
Bruker CorporationBRKR
$56.88Name : Bruker Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $8,622,894,080.00
EPSttm : 2.07
Bruker Corporation
$56.88
3.61%$2.13Float Short %
6.02
Margin Of Safety %
6
Put/Call OI Ratio
2.23
EPS Next Q Diff
-0.07
EPS Last/This Y
-0.53
EPS This/Next Y
0.37
Price
56.88
Target Price
72.38
Analyst Recom
2.07
Performance Q
-7.17
Relative Volume
0.91
Beta
1.17
Ticker: BRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | BRKR | 55.29 | 3.43 | 17.90 | 31031 |
| 2024-12-20 | BRKR | 56.97 | 3.43 | 0.04 | 31007 |
| 2024-12-23 | BRKR | 57.34 | 2.76 | 0.96 | 20993 |
| 2024-12-24 | BRKR | 58.25 | 2.73 | 9.00 | 21190 |
| 2024-12-26 | BRKR | 58.3 | 2.73 | 0.78 | 21199 |
| 2024-12-27 | BRKR | 58.44 | 2.70 | 22.20 | 21342 |
| 2024-12-30 | BRKR | 58.51 | 2.73 | 1.00 | 21486 |
| 2024-12-31 | BRKR | 58.66 | 2.69 | 2.07 | 21763 |
| 2025-01-02 | BRKR | 58.9 | 2.77 | 2.80 | 22066 |
| 2025-01-03 | BRKR | 59.75 | 2.77 | 0.74 | 21925 |
| 2025-01-06 | BRKR | 60.67 | 2.74 | 0.06 | 22069 |
| 2025-01-07 | BRKR | 61.27 | 2.74 | 0.03 | 22072 |
| 2025-01-08 | BRKR | 60.97 | 2.54 | 0.18 | 22548 |
| 2025-01-09 | BRKR | 60.95 | 2.54 | 0.18 | 22548 |
| 2025-01-10 | BRKR | 60.83 | 2.43 | 1.39 | 22874 |
| 2025-01-13 | BRKR | 62.98 | 2.41 | 0.17 | 23203 |
| 2025-01-14 | BRKR | 61.06 | 2.44 | 0.01 | 23131 |
| 2025-01-15 | BRKR | 57.46 | 2.50 | 6.05 | 22983 |
| 2025-01-16 | BRKR | 59 | 2.53 | 0.17 | 23219 |
| 2025-01-17 | BRKR | 56.91 | 2.23 | 0.27 | 23972 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | BRKR | 55.27 | 4.9 | 132.0 | 2.38 |
| 2024-12-20 | BRKR | 57.03 | 4.9 | 146.7 | 2.38 |
| 2024-12-23 | BRKR | 57.39 | 5.6 | 135.6 | 2.39 |
| 2024-12-24 | BRKR | 58.25 | 5.6 | 139.5 | 2.39 |
| 2024-12-26 | BRKR | 58.31 | 5.6 | 133.3 | 2.39 |
| 2024-12-27 | BRKR | 58.41 | 5.6 | 133.6 | 2.39 |
| 2024-12-30 | BRKR | 58.54 | 5.6 | 133.8 | 2.39 |
| 2024-12-31 | BRKR | 58.62 | 5.6 | 133.7 | 2.39 |
| 2025-01-02 | BRKR | 58.88 | 5.6 | 134.8 | 2.39 |
| 2025-01-03 | BRKR | 59.77 | 5.6 | 140.1 | 2.39 |
| 2025-01-06 | BRKR | 60.63 | 5.6 | 139.5 | 2.39 |
| 2025-01-07 | BRKR | 61.26 | 5.6 | 137.3 | 2.39 |
| 2025-01-08 | BRKR | 60.95 | 5.6 | 130.6 | 2.39 |
| 2025-01-09 | BRKR | 60.95 | 5.6 | 132.8 | 2.39 |
| 2025-01-10 | BRKR | 60.82 | 5.6 | 131.8 | 2.39 |
| 2025-01-13 | BRKR | 62.95 | 5.6 | 148.9 | 2.39 |
| 2025-01-14 | BRKR | 61.27 | 5.6 | 120.7 | 2.39 |
| 2025-01-15 | BRKR | 57.51 | 5.6 | 105.2 | 2.39 |
| 2025-01-16 | BRKR | 58.99 | 5.6 | 144.1 | 2.39 |
| 2025-01-17 | BRKR | 56.88 | 5.6 | 116.6 | 2.39 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | BRKR | 0.19 | 1.46 | 3.20 |
| 2024-12-20 | BRKR | 0.19 | 1.46 | 3.20 |
| 2024-12-23 | BRKR | 0.18 | 1.46 | 3.20 |
| 2024-12-24 | BRKR | 0.18 | 1.46 | 3.20 |
| 2024-12-26 | BRKR | 0.19 | 1.46 | 3.40 |
| 2024-12-27 | BRKR | 0.19 | 1.46 | 3.40 |
| 2024-12-30 | BRKR | 0.19 | 1.38 | 3.40 |
| 2024-12-31 | BRKR | 0.19 | 1.38 | 3.40 |
| 2025-01-02 | BRKR | 0.19 | 1.38 | 3.40 |
| 2025-01-03 | BRKR | 0.19 | 1.38 | 3.40 |
| 2025-01-06 | BRKR | 0.19 | 1.36 | 3.40 |
| 2025-01-07 | BRKR | 0.19 | 1.36 | 3.40 |
| 2025-01-08 | BRKR | 0.19 | 1.36 | 3.40 |
| 2025-01-09 | BRKR | 0.19 | 1.36 | 3.40 |
| 2025-01-10 | BRKR | 0.19 | 1.36 | 3.40 |
| 2025-01-13 | BRKR | 0.19 | 1.46 | 6.02 |
| 2025-01-14 | BRKR | 0.19 | 1.46 | 6.02 |
| 2025-01-15 | BRKR | 0.19 | 1.46 | 6.02 |
| 2025-01-16 | BRKR | 0.19 | 1.46 | 6.02 |
| 2025-01-17 | BRKR | 0.19 | 1.46 | 6.02 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.6
Avg. EPS Est. Current Quarter
0.74
Avg. EPS Est. Next Quarter
0.53
Insider Transactions
0.19
Institutional Transactions
1.46
Beta
1.17
Average Sales Estimate Current Quarter
962
Average Sales Estimate Next Quarter
821
Fair Value
60.57
Quality Score
79
Growth Score
93
Sentiment Score
10
Actual DrawDown %
40
Max Drawdown 5-Year %
-48.7
Target Price
72.38
P/E
27.39
Forward P/E
20.93
PEG
3.15
P/S
2.66
P/B
4.77
P/Free Cash Flow
55.03
EPS
2.08
Average EPS Est. Cur. Y
2.39
EPS Next Y. (Est.)
2.76
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
9.41
Relative Volume
0.91
Return on Equity vs Sector %
-2.2
Return on Equity vs Industry %
4.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
116.6
Bruker CorporationSector: Healthcare
Industry: Medical Devices
Employees: 9707
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
stock quote shares BRKR – Bruker Corporation Stock Price stock today
news today BRKR – Bruker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BRKR – Bruker Corporation yahoo finance google finance
stock history BRKR – Bruker Corporation invest stock market
stock prices BRKR premarket after hours
ticker BRKR fair value insiders trading